Government Regulation No. 242 / 2018 Coll.
Government Regulation amending Government Regulation No. 463 / 2013 Coll., on substance lists, as amended
Valid
Effective from 25.10.2018
242
GOVERNMENT REGULATION
of 17 October 2018
amending Government Regulation No 463 / 2013 Coll., on substance lists, as amended
The Government orders pursuant to § 44c (1) of Act No. 167 / 1998 Coll., on addictive substances and on the amendment of certain other laws, as amended by Act No. 273 / 2013 Coll.:
Annex No 4 to Government Regulation No 463 / 2013 Coll., on substance lists, reads as follows:
"Annex No 4 to Government Regulation No 463 / 2013 Coll.
List No 4 of psychotropic substances
| Mezinárodní nechráněný název (INN) v českém jazyce / obecný název | Další mezinárodní nechráněný název nebo další obecný název | Chemický název podle IUPAC | Poznámka |
|---|---|---|---|
| AB-CHMINACA | N-[(1S)-1-(aminokarbonyl)-2-methylpropyl]-1(cyklohexylmethyl)-1H-indazol-3-karboxamid | ||
| AB-FUBINACA | N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorbenzyl)-1H-indazol-3-karboxamid | ||
| AB-PINACA | N-[(1S)-1-(aminokarbonyl)-2-methylpropyl]-1-pentyl-1H-indazol-3-karboxamid | ||
| 4-Acetoxy-N-methyl-N-ethyltryptamin | 4-AcO-MET | {3-[2-(ethylmethylamino)ethyl]-1H-indol-4-yl} acetát | |
| o-Acetylpsilocin | 4-AcO-DMT | {3-[2-(dimethylamino)ethyl]-1H-indol-4-yl}acetát | Psilacetin |
| ADB-CHMINACA | N-[1-(aminokarbonyl)-2,2-dimethylpropyl]-1-(cyklohexylmethyl)-1H-indazol-3-karboxamid | ||
| ADB-FUBINACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-[(4-fluorfenyl)methyl]indazol-3-karboxamid | ||
| ADB-PINACA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazol-3-karboxamid | ||
| AH-7921 | 3,4-dichlor-N-{[1-(dimethylamino)cyklohexyl]methyl}benzamid | ||
| AL-LAD | (6aR,9R)-7-allyl-N,N-diethyl-6,6a,8,9-tetrahydro-4H-indol[4,3-fg]chinolin-9-karboxamid | 6-allyl-6-nor-LSD | |
| AM-2201 | [1-(5-fluorpentyl)-1H-indol-3-yl] (naftalen-1-yl)methanon | ||
| AMB-FUBINACA | FUB-AMB | Methyl 2-({1-[(4-fluorfenyl)methyl]-1H-indazol-3-karbonyl}amino)-3-methylbutanoát | MMB-FUBINACA |
| AMB-CHMICA | Methyl (2S)-2-{[1-(cyklohexylmethyl)indol-3-karbonyl]amino}-3-methylbutanoát | ||
| 5-Aminopropylindol | 5-API | 5-(2-aminopropyl)indol | |
| APICA | SDB-001, 2NE1 | N-(adamantan-1-yl)-1-pentyl-1H-indol-3-karboxamid | |
| APINACA | N-(adamantan-1-yl)-1-pentyl-1H-indazol-3-karboxamid | AKB48 | |
| bk-PMA | 2-amino-1-(4-methoxyfenyl)propan-1-on | ||
| Methedron | bk-PMMA | 1-(4-methoxyfenyl)-2-(methylamino)propan-1-on | |
| BMDP | 3,4-MDBC | 2-benzylamino-1-(3,4-methylendioxyfenyl)propan-1-on | |
| 2-Brommethkathinon | 2-BMC | (RS)-1-(2-bromfenyl)-2-(methylamino)propan-1-on | |
| 3-Brommethkathinon | 3-BMC | (RS)-1-(3-bromfenyl)-2-(methylamino)propan-1-on | |
| 4-Brommethkathinon | 4-BMC | (RS)-1-(4-bromfenyl)-2-(methylamino)propan-1-on | Brefedron |
| 25B-NBOMe | 2-(4-brom-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin | Cimbi-36 | |
| 25C-NBOMe | 2-(4-chlor-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin | 2C-C-NBOMe | |
| 25I-NBOH | 2-{[2-(4-jod-2,5-dimethoxyfenyl)ethylamino]methyl}fenol | 2C-I-NBOH; Cimbi-27 | |
| 25I-NBOMe | 2-(4-jod-2,5-dimethoxyfenyl)-N-[(2-methoxyfenyl)methyl]ethanamin | NBOMe-2C-I | |
| Bromo-Dragonfly | (2R)-1-(4-bromfuro[2,3-f][1]benzofuran-8-yl)propan-2-amin | ||
| Butylon | Bk-MBDB | 2-(methylamino)-1-[3,4-(methylendioxy)fenyl]butan-1-on | B1 |
| 2-Chloramfetamin | 2-CA | 1-(2-chlorfenyl)propan-2-amin | |
| 3-Chloramfetamin | 3-CA | 1-(3-chlorfenyl)propan-2-amin | |
| 4-Chloramfetamin | 4-CA | 1-(4-chlorfenyl)propan-2-amin | PCA |
| 4-Chlor-N-butylkathinon | 4-CBC | 2-(butylamino)-1-(4-chlorfenyl)propan-1-on | 4-Chlorbutylkathinon |
| 2-Chlorethkathinon | 2-CEC | 1-(2-chlorfenyl)-2-(ethylamino)propan-1-on | |
| 3-Chlorethkathinon | 3-CEC | 1-(3-chlorfenyl)-2-(ethylamino)propan-1-on | |
| 4-Chlorethkathinon | 4-CEC | 1-(4-chlorfenyl)-2-(ethylamino)propan-1-on | |
| 4-Chlorisobutyrfentanyl | 4-Cl-iBF | N-(4-chlorfenyl)-2-methyl-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid | |
| 2C-E | 2-(4-ethyl-2,5-dimethoxyfenyl)ethan-1-amin | ||
| 2-Chlormethamfetamin | 2-CMA | 1-(2-chlorfenyl)-N-methylpropan-2-amin | |
| 3-Chlormethamfetamin | 3-CMA | 1-(3-chlorfenyl)-N-methylpropan-2-amin | |
| 4-Chlormethamfetamin | 4-CMA | 1-(4-chlorfenyl)-N-methylpropan-2-amin | p-CMA |
| 2-Chlormethkathinon | 2-CMC | 1-(2-chlorfenyl)-2-(methylamino)propan-1-on | |
| 3-Chlormethkathinon | 3-CMC | 1-(3-chlorfenyl)-2-(methylamino)propan-1-on | |
| 4-Chlormethkathinon | 4-CMC | 1-(4-chlorfenyl)-2-(methylamino)propan-1-on | Clefedron |
| 2-Chlorpentedron | 2-CPD | 1-(2-chlorfenyl)-2-(methylamino)pentan-1-on | |
| 3-Chlorpentedron | 3-CPD | 1-(3-chlorfenyl)-2-(methylamino)pentan-1-on | |
| 4-Chlorpentedron | 4-CPD | 1-(4-chlorfenyl)-2-(methylamino)pentan-1-on | |
| 4-Chlor-α-pyrrolidinovalerofenon | 4-Cl-α-PVP | 1-(4-chlorfenyl)-2-(pyrrolidin-1-yl)pentan-1-on | |
| CUMYL-4CN-BINACA | SGT-78 | 1-(4-kyanobutyl)-N-(1-methyl-1-fenylethyl)indazol-3-karboxamid | |
| Cyklopentylfentanyl | Cyclopentyl-F; CP-F | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]cyklopentankarboxamid | |
| Cyklopropylfentanyl | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]cyklopropankarboxamid | ||
| Dimethoxyethylthiofenethylamin | 2C-T-2 | [4-(ethylsulfanyl)-2,5-dimethoxyfenethyl]amin | |
| Dimethoxypropylthiofenethylamin | 2C-T-7 | [4-(propylsulfanyl)-2,5-dimethoxyfenethyl]amin | |
| CP-47,497 | 2-[(1R,3S)-3-hydroxycyklohexyl]-5-(2-methyloktan-2-yl)fenol | ||
| CRA-13 | (naftalen-1-yl)[4-(pentyloxy)naftalen-1-yl]methanon | CB-13 | |
| DBZP | 1,4-dibenzylpiperazin | ||
| Deschlorketamin | 2-(methylamino)-2-fenyl-cyklohexanon | ||
| Despropionyl-2-fluor fentanyl | N-(2-fluorfenyl)-1-(2-fenylethyl)piperidin-4-amin | ||
| Despropionyl-4-fluor fentanyl | N-(4-fluorfenyl)-1-(2-fenylethyl)piperidin-4-amin | ||
| Dibutylon | Bk-DMBDB | 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)-1-butanon | Methylbutylon |
| Diclazepam | 2-chlorodiazepam | 7-chlor-5-(2-chlorfenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on | Ro 5-3448 |
| Diethyltryptamin | DET | N,N-diethyl-N-[2-(indol-3-yl)ethyl]amin | |
| Difenidin | DPD; 1,2-DEP; DIPH | 1-(1,2-difenylethyl)piperidin | AC1L4H21 |
| 5-Dihydrobenzofuranpyrovaleron | 5-DBFPV; MBPV | 1-(2,3-dihydrobenzofuran-5-yl)-2-(pyrrolidin-1-yl)pentan-1-on | |
| Dimethoxyamfetamin | DMA | (2RS)-1-(2,5-dimethoxyfenyl)propan-2-amin | |
| p-Methyl-4-methylaminorex | 4,4'-DMAR | 4-methyl-5-(4-methylfenyl)-4,5-dihydro-1,3-oxazol-2-amin | p4-DMAR |
| Dimethylheptyltetrahydrokanabinol | DMHP | 3-(1,2-dimethylheptyl)-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-benzo[c]chromen-1-ol | |
| 2,3-Dimethylmetkathinon | 2,3-DMMC | 1-(2,3-dimethylfenyl)-2-(methylamino)propan-1-on | |
| 2,4-Dimethylmetkathinon | 2,4-DMMC | 1-(2,4-dimethylfenyl)-2-(methylamino)propan-1-on | |
| 3,4-Dimethylmetkathinon | 3,4-DMMC | 1-(3,4-dimethylfenyl)-2-(methylamino)propan-1-on | |
| Dimethyltriptamin | DMT | N-[2-(indol-3-yl)ethyl]-N,N-dimethylamin | |
| Brolamfetamin | DOB | (2RS)-1-(4-brom-2,5-dimethoxyfenyl)propan-2-amin | |
| 2,5-Dimethoxy-4-chloramfetamin | DOC | 1-(4-chlor-2,5-dimethoxyfenyl)propan-2-amin | |
| Dimethoxyethylamfetamin | DOET | (2RS)-1-(4-ethyl-2,5-dimethoxyfenyl)propan-2-amin | |
| Dimethoxymetamfetamin | STP, DOM | (2RS)-1-(2,5-dimethoxy-4-methylfenyl)propan-2-amin | |
| 2,5-Dimethoxy-4-jodamfetamin | DOI | 1-(4-jod-2,5-dimethoxyfenyl)propan-2-amin | |
| 5-EAPB | 1-(1-benzofuran-5-yl)-N-ethylpropan-2-amin | ||
| 6-EAPB | 1-(1-benzofuran-6-yl)-N-ethylpropan-2-amin | ||
| Dimethylon | Bk-MDDMA | 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)propan-1-on | 3,4-methylendioxydi-methylkathinon |
| Methkathinon | Efedron | (2RS)-1-fenyl-2-(methylamino)propan-1-on | |
| Ephylon | MDEVP; bk-EBDP | 1-(benzo[d][1,3]dioxol-5-yl)-2-(ethylamino)pentan-1-on | N-ethyl-pentylon |
| ETH-LAD | (6aR,9R)-N,N-diethyl-7-ethyl-4,6,6a,7,8,9-hexahydroindol-[4,3-fg]chinolin-9-karboxamid | ||
| Etizolam | AHR 3219; Depas | 4-(2-chlorfenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f] [1,2,4]triazolo[4,3-a][ 1,4]diazepin | |
| Ethylfenidát | (RS)-ethyl-2-fenyl-2-piperidin-2-ylacetát | ||
| 2-Ethylmethkathinon | 2-EMC | (RS)-2-methylamino-1-(2-ethylfenyl)propan-1-on | |
| 3-Ethylmethkathinon | 3-EMC | (RS)-2-methy lamino-1-(3-ethylfenyl)propan-1-on | |
| 4-Ethylmethkathinon | 4-EMC | (RS)-2-methylamino-1-(4-ethylfenyl)propan-1-on | |
| N-ethylnorpentedron | N-ethylpentedron | 2-(ethylamino)-1-fenyl-pentan-1-on | α-ethylaminopentiofenon |
| Etryptamin | 3-(2-aminobutyl)indol | ||
| 2-Fluoramfetamin | 2-FA | 1-(2-fluorfenyl)propan-2-amin | |
| 3-Fluoramfetamin | 3-FA | 1-(3-fluorfenyl)propan-2-amin | |
| 4-Fluoramfetamin | 4-FA | 1-(4-fluorfenyl)propan-2-amin | |
| 5F-ADBICA | N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(5-fluorpentyl)-1H-indol-3-karboxamid | ||
| 5F-AKB48 | N-(adamantan-1-yl)-1-(5-fluorpentyl)-1H-indazol-3-karboxamid | ||
| 5F-AMB-PINACA | 5F-AMB | Methyl-2-({[1-(5-fluorpentyl)-1H-indazol-3-yl]karbonyl}amino)-3-methylbutanoát | 5F-AMP |
| Fentanyl butanamid analog | Butyrfentanyl | N-fenyl-N-[1-(2-fenylethyl)-4-piperidinyl]-butanamid | |
| 3F-Fenmetrazin | 3-FPM; PAL-593 | 2-(3-fluorofenyl)-3-methylmorfolin | |
| 4F-Fenmetrazin | 4-FPM | 2-(4-fluorofenyl)-3-methylmorfolin | |
| 4-Fluor-butyrfentanyl | 4F-BF | N-(4-fluorofenyl)-N-[(1-(2-fenylethyl)-4-piperidinyl)]butanamid | |
| 2-Fluorethkathinon | 2-FEC | 1-(2-fluorfenyl)-2-(ethylamino)propan-1-on | |
| 3-Fluorethkathinon | 3-FEC | 1-(3-fluorfenyl)-2-(ethylamino)propan-1-on | |
| 4-Fluorethkathinon | 4-FEC | 1-(4-fluorfenyl)-2-(ethylamino)propan-1-on | |
| 2-Fluorfentanyl | Ortofluorfentanyl | N-(2-fluorfenyl)-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid | 2-FF, o-FF |
| 3-Fluorfentanyl | Metafluorfentanyl | N-(3-fluorfeny)-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid | 3-FF, m-FF |
| 4-Fluorisobutyrfentanyl | 4F-iBF | N-(4-fluorfenyl)-2-methyl-N-[1-(2-fenylethyl)-4-piperidinyl]propanamid | |
| 2-Fluormethamfetamin | 2-FMA | (RS)-1-(2-fluorfenyl)-N-methylpropan-2-amin | |
| 3-Fluormethamfetamin | 3-FMA | (RS)-1-(3-fluorfenyl)-N-methylpropan 2-amin | |
| 4-Fluormethamfetamin | 4-FMA | (RS)-1-(4-fluorfenyl)-N-methylpropan-2-amin | |
| 2-Fluormethkathinon | 2-FMC | 1-(2-fluorfenyl)-2-(methylamino)propan-1-on | |
| 3-Fluormethkathinon | 3-FMC | 1-(3-fluorfenyl)-2-(methylamino)propan-1-on | |
| 4-Fluormethkathinon | 4-FMC | 1-(4-fluorfenyl)-2-(methylamino)propan-1-on | Flefedron |
| 4-Fluormethylfenidát | 4F-MPH; 4-FMPH | Methyl-2-(4-fluorfenyl)-2-(2-piperidyl)acetát | 4F-TMP |
| 4-Fluorpentedron | 4-FPD; 4-F-pentedron | 1-(4-fluorfenyl)-2-(methylamino)pentan-1-on | |
| 5F-PB-22; 5F-QUPIC | 8-chinolinyl ester kyseliny 1-(5-fluorpentyl)-1H-indol-3-karboxylové | ||
| 5F-MDMB-PINACA | 5F-ADB | methyl (S)-2-({[1-(5-fluorpentyl)-1H-indazol-3-yl]karbonyl}amino)-3,3-dimethylbutanoát | |
| 5FUR-144 | [1-(5-fluorpentyl)-1H-indol-3-yl](2,2,3,3-tetramethylcyklopropyl)methanon | XLR-11 | |
| Furanylfentanyl | FU-F | N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]-furan-2-karboxamid | 2-furanoylfentanyl |
| 4-Hydroxy-N-methyl-N-ethyl tryptamin | 4-HO-MET | 3-{2-[ethyl(methyl)amino]ethyl}-1H-indol-4-ol | Metocin; Methylcybin |
| 4-Hydroxy-N-methyl-N-isopropyl tryptamin | 4-HO-MiPT | 3-{2-[methyl(propan-2-yl)amino]ethyl}-1H-indol-4-ol | Miprocin |
| Hydroxytenamfetamin | (2RS)-N-hydroxy-1-[3,4-(methylendioxy)fenyl]propan-2-amin | ||
| (iso)Butyryl-F-fentanyl N-benzyl analog | N-(1-benzylpiperidin-4-yl)-N-(4-fluorfenyl)butanamid | ||
| Joddimethoxyfenethylamin | 2C-I | (4-jod-2,5-dimethoxyfenylethyl)amin | |
| JWH-018 | (naftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon | ||
| JWH-073 | (1-butyl-1H-indol-3-yl)(naftalen-1-yl)methanon | ||
| JWH-081 | (4-methoxynaftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon | ||
| JWH-122 | (4-methylnaftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon | ||
| JWH-200 | [1-(2-morfolinoethyl)-1H-indol-3-yl](naftalen-1-yl)methanon | ||
| JWH-210 | (4-ethylnaftalen-1-yl)(1-pentyl-1H-indol-3-yl)methanon | ||
| JWH-250 | 2-(2-methoxyfenyl)-1-(1-pentyl-1H-indol-3-yl)ethan-1-on | ||
| JWH-398 | (4-chlornaftalen-1-y 1)(1-pentyl-1H-indol-3-yl)methanon | ||
| Kathinon | (2S)-2-amino-1-fenylpropan-1-on | ||
| (+)-Lysergid | LSD, LSD-25 | (+)-8β-(3,3-dimethylureido)-6-methyl-9,10-didehydroergolin | |
| 1p-LSD, 1P-LAD | diethylamid kyseliny 1-propionyl lysergové; (6aR,9R)-N,N-diethyl-7-methyl-4-propanoyl-6,6a,8,9-tetrahydroindol[4,3-fg]chinolin-9-karboxamid | ||
| 5-MeO-MiPT | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-methylpropan-2-amin; 5-methoxy-N-methyl-N-iso-propyl tryptamin | ||
| Methoxfenidin | MXP | 1-[1-(2-methoxyfenyl)-2-fenylethyl]piperidin | 2-MeO-difenidin |
| Methoxyacetylfentanyl | Methoxy-AcF | 2-methoxy-N-fenyl-N-[1-(2-fenylethyl)piperidin-4-yl]acetamid | |
| 2-Methylamfetamin | 2-MA | (2RS)-1-(2-methylfenyl)propan-2-amin | |
| 3-Methylamfetamin | 3-MA | (2RS)-1-(3-methylfenyl)propan-2-amin | |
| 4-Methylamfetamin | 4-MA | (2RS)-1-(4-methylfenyl)propan-2-amin | |
| 2-MAPB | 1-(benzofuran-2-yl)-N-methylpropan-2-amin | ||
| 3-MAPB | 1-(benzofuran-3-yl)-N-methylpropan-2-amin | ||
| 4-MAPB | 1-(benzofuran-4-yl)-N-methylpropan-2-amin | ||
| 5-MAPB | 1-(benzofuran-5-yl)-N-methylpropan-2-amin | ||
| 6-MAPB | 1-(benzofuran-6-yl)-N-methylpropan-2-amin | ||
| 7-MAPB | 1-(benzofuran-7-yl)-N-methylpropan-2-amin | ||
| MBZP | 1-benzyl-4-methylpiperazin | ||
| 2-Methyl-N,N-dimethylkathinon | 2-MDMC | 1-(2-methylfenyl)-2-(dimethylamino)propan-1-on | |
| 3-Methyl-N,N-dimethylkathinon | 3-MDMC | 1-(3-methylfenyl)-2-(dimethylamino)propan-1-on | |
| 4-Methyl-N,N-dimethylkathinon | 4-MDMC | 1-(4-methylfenyl)-2-(dimethylamino)propan-1-on | |
| m-Chlorfenylpiperazin | mCPP | 1-(3-chlorfenyl)piperazin | |
| Tenamfetamin | MDA | (2RS)-1-[3,4-(methylendioxy)fenyl]propan-2-amin | |
| MDAI | 5,6-(methylendioxy)indan-2-amin | ||
| Ethyltenamfetamin | MDE, MDEA | (2RS)-N-ethyl-1-[3,4-(methylendioxy)fenyl]propan-2-amin | |
| Ethylon | bk-MDEA | 2-ethylamino-1-(3,4-methylendioxy fenyl)propan-1-on | |
| Methyltenamfetamin | MDMA | (2RS)-N-methyl-1-[3,4-(methylendioxy)fenyl]propan-2-amin | |
| MDMB-CHMICA | N-[[1-(cyklohexylmethyl)-1H-indol-3-yl]karbonyl]-3-methyl-valin, methyl ester | ||
| MDMB-FUBINACA | 2-[[1-[(4-fluorfenyl)methyl]indazol-3-karbonyl]amino]-3,3-dimethylbutanoát | ||
| MDPHP; 3,4-MDPHP | 1-(1,3-benzodioxol-5-yl)-2-(pyrrolidin-1-yl)hexan-1-on | ||
| 2,3-Methylendioxymethkathinon | 2,3-MDMC | 1-(1,3-benzodioxol-4-yl)-2-(methylamino)propan-1-on | |
| 3,4-Methylendioxypyrovaleron | MDPV | 1-[3,4-(methylendioxy)fenyl]-2-(pyrrolidin-1-yl)pentan-1-on | MDPK |
| 2-Methylethkathinon | 2-MEC | 2-(ethylamino)-1-(2-methylfenyl)propan-1-on | |
| 3-Methylethkathinon | 3-MEC | 2-(ethylamino)-1-(3-methylfenyl)propan-1-on | |
| 4-Methylethkathinon | 4-MEC | 2-(ethylamino)-1-(4-methylfenyl)propan-1-on | |
| 4-Methylmetkathinon | Mefedron | 2-(methylamino)-1-(4-methylfenyl)propan-1-on | |
| 5-MeO-AMT | 5-methoxy-α-methyltryptamin | ||
| 4-Methoxybutyr fentanyl | 4-MeO-BF | N-(4-methoxyfenyl)-N-[1-(2-fenylethyl)piperidin-4-yl] butanamid | |
| 5-MeO-DALT | N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-N-(prop-2-en-1-yl)prop-2-en-1-amin | ||
| 3-Methoxyfencyklidin | 3-MeO-PCP | 1-[1-(3-methoxyfenyl)cyklohexyl]piperidin | |
| Meskalin | 3,4,5-trimethoxyfenethylamin | ||
| Methoxetamin | MXE | 2-(ethylamino)-2-(3-methoxyfenyl)cyklohexanon | |
| Methylaminorex | (±)-5-fenyl-4-methyl-4,5-dihydrooxazol-2-amin | ||
| α-Methylfentanyl butanamid analog | BF; B-F | 2-methyl-N-fenyl-N-[1-(1-fenylpropan-2-yl)piperidin-4-yl]propanamid | |
| 2-Methyl-N-ethylnorpentedron | 2-MEAP | 2-(ethylamino)-1-(2-methylfenyl)-pentan-1-on | |
| 3-Methyl-N-ethylnorpentedron | 3-MEAP | 2-(ethylamino)-1-(3-methylfenyl)-pentan-1-on | |
| 4-Methyl-N-ethylnorpentedron | 4-MEAP | 2-(ethylamino)-1-(4-methylfenyl)-pentan-1-on | |
| Methylon | Bk-MDMA | 2-(methylamino)-1-[3,4-(methylendioxy)fenyl]propan-1-on | |
| 2-Methylmetamfetamin | 2-MMA | 1-(2-methylfenyl)-N-methylpropan-2-amin | |
| 3-Methylmetamfetamin | 3-MMA | 1-(3-methylfenyl)-N-methylpropan-2-amin | |
| 4-Methylmetamfetamin | 4-MMA | 1-(4-methylfenyl)-N-methylpropan-2-amin | |
| 2-Methylmetkathinon | 2-MMC | 2-(methylamino)-1-(2-methylfenyl)propan-1-on | |
| 3-Methylmetkathinon | 3-MMC | 2-(methylamino)-1-(3-methylfenyl)propan-1-on | |
| Methoxytenamfetamin | MMDA | (2RS)-1-[5-methoxy-3,4-(methylendioxy)fenyl]propan-2-amin | |
| 4-MPD | 1-(4-methylfenyl)-2-methylamino-pentan-1-on | ||
| Methylthienylpropamin | MPA | N-methyl-1-(thiofen-2-yl)propan-2-amin | |
| MT-45 | 1-cyklohexyl-4-(1,2-difenylethyl)piperazin | ||
| 2-Methylthioamfetamin | 2-MTA | (2RS)-1-[2-(methylsulfanyl)fenyl]propan-2-amin | |
| 3-Methylthioamfetamin | 3-MTA | (2RS)-1-[3-(methylsulfanyl)fenyl]propan-2-amin | |
| 4-Methylthioamfetamin | 4-MTA | (2RS)-1-[4-(methylsulfanyl)fenyl]propan-2-amin | |
| Mexedron | 4-MMC-oMe; MEX | (3-methoxy-2-(methylamino)-1-(p-tolyl)propan-1-on | |
| Naftylpyrovaleron | Nafyron | 1-(naftalen-2-yl)-2-(pyrrolidin-1-yl)pentan-1-on | 0-2482 |
| N-methyl-2-aminoindan | N-methyl-2AI | 2,3-dihydro-N-methyl-1H-inden-2-amin | NM-2AI |
| NM-2201,CBL-2201 | naftalen-1-yl-1-(5-fluorpentyl)-1H-indol-3-karboxylát | ||
| OCfentanyl | A-3217 | N-(2-fluorfenyl)-2-methoxy-N-[1-(2-fenylethyl)piperidin-4-yl]acetamid | |
| o-Desmethyltramadol | ODT | 3-{-2-[(dimethylamino)methyl]-1-hydroxycyklohexyl}fenol | |
| Parahexyl | 3-hexyl-6,6,9-trimethyl-7,8,9,10-tetrahydro-6H-benzo[c]chromen-1-ol | ||
| Eticyklidin | PCE | N-ethyl-1-fenylcyklohexylamin | |
| Pentedron | pentedron | 1-fenyl-2-(methylamino)pentan-1-on | |
| p-Fluorfenylpiperazin | pFPP | 1-(4-fluorfenyl)piperazin | |
| Methoxyamfetamin | PMA | (2RS)-1-(4-methoxyfenyl)propan-2-amin | |
| Methoxymetamfetamin | PMMA | 1-(4-methoxyfenyl)-N-methylpropan-2-amin | |
| Psilocybin | 3-[2-(dimethylamino)ethyl]-1H-indol-4-yl-dihydrogenfosfát | ||
| Psilocin | Psilotsin | 3-[2-(dimethylamino)ethyl]-1H-indol-4-ol | |
| PV8, α-PHPP | 1-fenyl-2-(pyrrolidin-1-yl)-1-heptan-1-on | ||
| PV9, α-POP | 1-fenyl-2-(pyrrolidin-1-yl)-1-oktan-1-on | ||
| α-PVP | 1-fenyl-2-(pyrrolidin-1-yl)-1-pentan-1-on | ||
| α-PVT | 2-(pyrrolidin-1-yl)-1-(thiofen-2-yl)pentan-1-on | ||
| α-Pyrrolidinohexanofenon | α-PHP | 1-fenyl-2-(pyrrolidin-1-yl)-1-hexan-1-on | |
| α-Pyrrolidinoisohexanofenon | α-PiHP | 1-fenyl-4-methyl-2-(pyrrolidin-1-yl)-1-pentan-1-on | |
| Rolicyklidin | PHP, PCPY | 1-(1-fenylcyklohexy l)pyrrolidin | |
| Salvinorin A | Salvinorin A | methyl-(2RS,4aR,6aR,7R,9RS,10aRS,10bR)-9-acetoxy-2-(furan-3-yl)-6a, 10b-dimethyl-4,10-dioxododekahydro-1H-benzo[ƒ]isochromen-7-karboxylát | |
| Tenocyklidin | TCP | 1-[1-(2-thienyl)cyklohexyl]piperidin | |
| 1-(3-Trifluormethylfenyl)piperazin | TFMPP | 1-[3-(trifluormethyl)fenyl]piperazin | |
| Tetrahydrofuranfentanyl | THF-F | N-(1-fenylethylpiperidin-4-yl)-N-fenyltetrahydrofuran-2-karboxamid | |
| Tetrahydrokanabinol | THC | Δ6a(10a)-, Δ6a(7)-, Δ7-, Δ8-, Δ10-, Δ9(11)-tetrahydrokanabinoly a jejich stereoizomery | |
| TH-PVP | 2-(pyrrolidin-1-yl)-1-(5,6,7,8-tetrahydronaftalen-2-yl)pentan-1-on | ||
| Trimethoxyamfetamin | TMA | (2RS)-1-(3,4,5-trimethoxyfenyl)propan-2-amin | |
| Trimethoxyamfetamin-2 | TMA-2 | (2RS)-1-(2,4,5-trimethoxyfenyl)propan-2-amin | |
| 2,4,6-Trimethoxyamfetamin | TMA-6 | 1-(2,4,6-trimethoxyfenyl)propan-2-amin | |
| UR-144 | (1-pentyl-1H-indol-3-yl)-(2,2,3,3-tetramethylcyklopropyl)methanon | TMCP-018 | |
| U-47700 | 3,4-dichlor-N-[2-(dimethylamino)cyklohexyl]-N-methylbenzamid | ||
| U-49900 | 3,4-dichlor-N-[2-(diethylamino)cyklohexyl]-N-methylbenzamid | ||
| U-51,754 | 2-(3,4-dichlorfenyl)-N-[2-(dimethylamino)cyklohexyl]-N-methylacetamid | ||
| Valerylfentanyl | TCE, VF | N-fenyl-N-[1-(2-fenylethyl)-4-piperidyl]pentanamid; fentanyl pentanamid analog | |
| W-15 | 4-chlor-N-(1-fenethylpiperidin-2-yliden)benzensulfonamid | ||
| W-18 | 4-chlor-N-(1-[2-(4-nitrofenyl)ethyl]-piperidin-2-yliden)benzensulfonamid |
Including stereoisomers of psychotropic substances, except for the explicit exceptions listed in this list in all cases where such stereoisomers may exist according to the specific chemical designation and salts of psychotropic substances listed in this list in all cases where they may exist. ';
This Regulation has been notified in accordance with Directive (EU) 2015 / 1535 of the European Parliament and of the Council of 9 September 2015 laying down a procedure for the provision of information in the field of technical and information society services.
Efficacy
This Regulation shall enter into force on the day of its publication.
Prime Minister:
Ing. Babiš v. r.
Minister for Health:
Mgr. et Mgr. Vojtěch, MHA, v. r.
Sign in for notes, favorites and notifications
Regulation Information
| Citation | Government Regulation No. 242 / 2018 Coll., amending Government Regulation No. 463 / 2013 Coll., on substance lists, as amended |
|---|---|
| Regulation Type | - |
| Author | - |
| Collection | Code of Laws |
| Date of Promulgation | 25.10.2018 |
|---|---|
| Effective from | 25.10.2018 |
| Effective until | - |
| Status | Valid |
The regulation text is for informational purposes only.
Comments 0